Clovis Oncology, Inc. (26)

Browse by Contract Category

Contracts

Distribution Agreement, dated August 16, 2021, by and among Clovis Oncology, Inc., J.P. Morgan Securities LLC and BofA Securities, Inc (Filed With SEC on August 16, 2021)
Clovis Oncology, Inc. 2021 Employee Stock Purchase Plan (Filed With SEC on August 4, 2021)
Clovis Oncology, Inc. Amended and Restated 2020 Stock Incentive Plan (Filed With SEC on August 4, 2021)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 26, 2020)
Indemnification Agreement, dated as of July 12, 2021, by and between Clovis Oncology, Inc. and Ronit Simantov (Filed With SEC on July 13, 2021)
Distribution Agreement, dated May 17, 2021, by and among Clovis Oncology, Inc., J.P. Morgan Securities LLC and BofA Securities, Inc (Filed With SEC on May 17, 2021)
Indemnification Agreement, dated as of May 3, 2021, by and between Clovis Oncology, Inc. and Thomas C. Harding (Filed With SEC on May 5, 2021)
Employment Agreement, dated as of May 4, 2021, by and between Clovis Oncology, Inc. and Thomas C. Harding (Filed With SEC on May 5, 2021)
License and Collaboration Agreement, dated September 20, 2019 by and between 3B Pharmaceuticals GmbH and Clovis Oncology, Inc (Filed With SEC on February 25, 2021)
Indenture, dated as of November 17, 2020, by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the New 2024 Notes (Filed With SEC on November 17, 2020)
Form of Exchange and Purchase Agreement (Filed With SEC on November 5, 2020)
Form of Indenture, to be entered into by and between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee, relating to the New 2024 Notes (Filed With SEC on November 5, 2020)
Clovis Oncology, Inc. 2020 Stock Incentive Plan (Filed With SEC on August 7, 2020)
Form of Clovis Oncology, Inc. 2020 Stock Incentive Plan Restricted Stock Unit Grant Notice and Agreement (Filed With SEC on June 4, 2020)
Form of Clovis Oncology, Inc. 2020 Stock Incentive Plan Option Grant Notice and Agreement (Filed With SEC on June 4, 2020)
Underwriting Agreement, dated May 18, 2020 (Filed With SEC on May 21, 2020)
Indenture, dated as of August 13, 2019, by and between Clovis Oncology, Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on August 13, 2019)
Financing Agreement, dated as of May 1, 2019 among Clovis Oncology, Inc. (the Company), certain subsidiaries of the Company named therein, as Guarantors, the Lenders from time to... (Filed With SEC on May 2, 2019)
Pledge and Security Agreement, dated as of May 1, 2019 among each of the Grantors party thereto and the Administrative Agent party thereto (Filed With SEC on May 2, 2019)
Amendment to Employment Agreement, by and between Clovis Oncology, Inc. and Paul Gross, dated March 14, 2019 (Filed With SEC on March 14, 2019)
Amendment to Employment Agreement, by and between Clovis Oncology, Inc. and Gillian Ivers-Read, dated March 14, 2019 (Filed With SEC on March 14, 2019)
Amendment to Employment Agreement, by and between Clovis Oncology, Inc. and Daniel Muehl, dated March 14, 2019 (Filed With SEC on March 14, 2019)
Amendment to Employment Agreement, by and between Clovis Oncology, Inc. and Patrick Mahaffy, dated March 14, 2019 (Filed With SEC on March 14, 2019)
Employment Agreement, dated as of July 6, 2017, between Clovis Oncology, Inc. and Paul Gross (Filed With SEC on February 28, 2019)
Indemnification Agreement, dated as of September 9, 2016, between Clovis Oncology, Inc. and Paul Gross (Filed With SEC on February 28, 2019)
Amended and Restated Employment Agreement, dated as of February 27, 2019, by and between Clovis Oncology, Inc. and Clovis Oncology UK Limited and Lindsey Rolfe (Filed With SEC on February 28, 2019)